Last reviewed · How we verify
NCT04834271
Effects of Blood Flow Restriction Training in Rotator Cuff Related Shoulder Pain
NA trial testing Side-lying external rotation exercise with a dumbbell in Subacromial Pain Syndrome. Withdrawn.
1 December 2021
Quick facts
| Lead sponsor | University of Alcala |
|---|---|
| Phase | NA |
| Status | Withdrawn |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | double |
| Primary purpose | treatment |
| Start date | 1 March 2021 |
| Primary completion | 1 December 2021 |
| Estimated completion | 1 June 2022 |
| Sites | 1 location across Spain |
Drugs / interventions tested
- Side-lying external rotation exercise with a dumbbell
- Side-lying external rotation exercise with a dumbbell with 40% arterial occlusion pressure blood flow restriction
- Side-lying external rotation exercise with a dumbbell with 80% arterial occlusion pressure blood flow restriction
Conditions studied
- Subacromial Pain Syndrome — all drugs for Subacromial Pain Syndrome →
Sponsor
University of Alcala
Who can join
Adults 18 to 65, any sex, with Subacromial Pain Syndrome. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Blood flow restriction training is widespread in sport performance areas, where it has proven to be beneficial in strength and hypertrophy development. However, there are only few studies related to its effects on subjects with pathology, and currently, there is no recent clinical trial evaluating its effects on patients with RCRSP. We are aiming to define the potential benefits, acute and short-term effects of adding blood flow restriction to a low-load exercise training for patients with RCRSP.
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT04834271
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Subacromial Pain Syndrome
Currently open trials in the same condition.
- NCT07415967 — The Effect of a Dual-Task Technique-Based Exercise Program on Clinical Outcomes in Rotator Cuff Related Shoulder Pain · NA · recruiting
- NCT07324343 — Which Patient Group Shows Greater Improvement With Patient Education Alone in Rotator Cuff-Related Shoulder Pain? - A Co · NA · recruiting
- NCT06409442 — Effects of Corrective External Support and Regional Vibration Applications in Subacromial Pain Syndrome · NA · recruiting
- NCT06449534 — The Effect of the Treatment Environment on Pain, Function, Self Efficacy and Satisfaction in RCRSP · NA · recruiting
- NCT04923477 — Therapeutic Exercise for Rotator Cuff Tendinopathy / Subacromial Pain Syndrome - Outcomes and Mechanisms · NA · recruiting
Other University of Alcala trials
Trials by the same sponsor.
- NCT06599164 — Evaluation of Vastus Medialis Muscle Inhibition in Indoor Soccer Players With and Without ACL Injury · not yet recruiting
- NCT06587412 — Treatment of Lateral Epicondylalgia With Shock Waves · NA · recruiting
- NCT07333443 — Caffeine and Sport Climbing Performance · NA · completed
- NCT07015008 — Sleep and Maximal Fat Oxidation · NA · completed
- NCT06723821 — Noninvasive Neuromodulation in the Management of Post-COVID Musculoskeletal Pain · NA · recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT04834271 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by University of Alcala
- Last refreshed: 22 November 2022
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04834271.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing